188663-13-0

Upstream product

• 4254-14-2 (2R)-propane-1,2-diol 
• 100-52-7 benzaldehyde 

Downstream Products

• 940879-09-4 (2R)-2-(phenylcarbonyloxy)propyl (2S)-2-(tert-butoxycarbonyl)amino-3-(3,4-dihydroxyphenyl)propanoate 
• 940879-06-1 (2R)-2-(phenylcarbonyloxy)propyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate mesylate 
• 871580-90-4 (1R)-2-bromo-1-methylethyl benzoate 

Relevant academic research and scientific papers

PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF A LEVODOPA PRODRUG AND METHODS OF USE

Pharmaceutical compositions and oral dosage forms of (2R)-2-phenylcarbonyloxypropyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate mesylate and methods of treating diseases comprising orally administering such pharmaceutical compositions and dosage forms

Levodopa Prodrug Mesylate Hydrate

Crystalline (2R)-2-phenylcarbonyloxypropyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate mesylate, hydrate, methods of making the hydrate, pharmaceutical compositions containing the hydrate, and methods of using the hydrate to treat diseases or disorders

Levodopa prodrug mesylate, compositions thereof, and uses thereof

(2R)-2-Phenylcarbonyloxypropyl(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate mesylate and crystalline form thereof, methods of making the same, pharmaceutical compositions thereof, and methods of using the same to treat diseases or disorders such as Parki